News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Merle Haberman, MHA

Articles by Merle Haberman, MHA

The Rate, Pattern, and Cost of Use of Antiparkinsonian Agents Among Patients Treated for Schizophrenia in a Managed Care Setting

ByHaya Ascher-Svanum, PhD,John S. Kennedy, MD,David Lee, PhD,Merle Haberman, MHA

January 1st 2004

Latest Updated Articles

The Rate, Pattern, and Cost of Use of Antiparkinsonian Agents Among Patients Treated for Schizophrenia in a Managed Care Setting
Published: January 1st 2004 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Exploring Identity, Appearance Experiences Among Patients With Alopecia

Real-World Evidence Backs Acalabrutinib in CLL Care

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text